New Clinical Research Study is Seeking Participants Diagnosed with Skin Lupus

This study is the first study for individuals with cutaneous lupus erythematosus (CLE) to evaluate the safety, tolerability, and efficacy of an investigational medication. Clinical trials are critical in the search for a better life for people with lupus. While clinical studies are critical, it's important to know the facts about research before deciding whether or not to participate. People who have been diagnosed with skin lupus for at least 18 months and who are struggling to control their symptoms may be eligible to participate in this study.

Benefits
There are many possible benefits to study participation.

Participants will receive:
 More knowledge about their type of skin lupus
 Ongoing study-related medical care (such as exams and lab tests)
 Sunscreen throughout study participation
 Possible benefits of study medication
 Access to the latest research related to individuals with these forms of skin lupus
 Compensation for time


To be included in the trial participants must:
1. Be 18 years or older
2. Have a clinical diagnosis of DLE (discoid lupus erythematosus )or SCLE (subcutaneous lupus erythematosus) for more than 16 weeks before screening for the study
3. Have active skin lesions
4. Be in good general health other than a lupus diagnosis

Exclusion Criteria (other exclusion criteria not listed here may apply)

1. History of any significant major uncontrolled diseases
2. Pregnant or nursing

For more information about the study, please email us or call us at 619-542-0013.
www.MedDerm.net